We examined the impact of clinical complexity defined by comorbidity count and illness burden on comprehensive diabetes care, including blood pressure, glycemic, and lipid management.
Antiretroviral drugs have replaced hospitalization and other services as the most costly component of HIV care, except in patients with especially advanced HIV.
An observational study of 42 successful programs to improve primary care management of cardiovascular risk showed the impact of a strong primary care system.
Implementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.
For future studies focusing on quality of care from the background of the Chronic Care Model, the PACIC short form is appropriate.
We estimate the future net tax contributions from an IVF-conceived child to highlight that removing barriers to fertility treatments can have long-term economic benefits.
The editor in chief of Evidence-Based Diabetes Management welcomes those coming to the ADA Scientific Sessions to attend sessions featuring faculty from Joslin Diabetes Center.
A cancer pain control program for inpatients based on electronic health record–based automatic screening provided effective pain relief and achieved high satisfaction among patients and physicians.
The prevalence and predictors of hypoglycemia in South Korean patients with type 2 diabetes were evaluated using a nationwide healthcare database.
Looking to the future of bronchiectasis treatment, Panagis Galiatsatos, MD, MHS, outlines challenges in the current therapeutic landscape and discusses ways to potentially improve care.
Venous thromboembolism during or after recent hospitalization for medical illness contributes a substantial economic burden to society across all hospital and ambulatory care delivered.
This article details best practices to help healthcare organizations to understand consumers across the spectrum of care and to engage with patients and equip them with accurate, accessible pricing information.
Increasing adherence to inhaled corticosteroids for Medicaid-enrolled children with asthma could cost-effectively decrease both Medicaid spending and adverse clinical outcomes.
Quality improvement methodology was implemented to ensure that patients receiving medications for attention-deficit/hyperactivity disorder (ADHD) returned for an appointment within 30 days of initiating medication.
The authors evaluated the clinical applicability, accuracy, and implications of using an automated risk calculator and risk-based decision tool in an integrated health system.
Patients receiving care for advanced non—small cell lung cancer in small, independent oncology practices are more likely to receive chemotherapy in the last 30 days of life.
Despite concerns about rising patient costs for expensive care, we find that many patients face only moderately rising costs for physician care.
Healthcare costs are elevated for patients on chronic opioid therapy; nonadherence to the opioid regimen, based on urine drug monitoring results, further increases costs.
Co-payments for preventive services can discourage breast and cervical cancer screening among Medicaid enrollees, particularly breast cancer screening, which is more costly and time-consuming.
An examination of hospitalization patterns in patients with multiple sclerosis with a focus on the association with time and patient characteristics.
Three approaches to prospective patient identification for care management programs were compared: predictive modeling, selection by primary care physician, and a combination of both.
Significant additional outreach and engagement strategies and incentives are likely required to increase adoption and ongoing use of health risk assessment tools among target populations.
A new nursing-driven diabetes education process established within a patient-centered primary care model significantly improved diabetes control for veterans at the Albany Stratton VA Medical Center.
Men in a VA rehabilitation unit who had osteoporosis were older and thinner, but otherwise similar (metabolic and functional status) to control subjects.